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1097-93 Paradoxical Utilization of Invasive Cardiac Procedures 
for Patients With Non-ST-Segment Elevation Myocardial 
Infarction: An American-Canadian Comparison From 
the CRUSADE Initiative and Canadian Registries
Mohammad Zia, Shaun G. Goodman, Matthew T. Roe, Jyotsna Mulgand, Anatoly 
Langer, Mary Tan, E. Magnus Ohman, W. Brian Gibler, Charles V. Pollack, Jr., Eric D. 
Peterson, Canadian Heart Research Centre, St. Michael's Hospital, University of Toronto, 
Toronto, ON, Canada, Duke Clinical Research Institute, Durham, NC
Background: Clinical trial evidence supports an early invasive strategy for treatment of
pts with high-risk non–ST-segment elevation (NSTE) acute coronary syndromes (ACS).
This approach has not been evaluated in contemporary practice in North America.
Methods: We included NSTEMI pts (CK-MB or troponin >upper limit of normal) from the
US CRUSADE Initiative (n=38,373; 394 hospitals, 49 states, 2000–02) and the first
Canadian ACS (n=5,312 suspected ACS; 51 hospitals, 9 provinces, 1999–2001), and
second Canadian (n=1,258 suspected NSTE ACS; 31 hospitals, 7 provinces, 2002–03)
Registries. Pts were divided into risk categories by a modified PURSUIT score.
Results: Compared with Canadians, US pts were younger, more likely to be female and
to have a higher rate of prior hypertension, diabetes, heart failure, revascularization, and
initial ST depression (all p<0.0001). US pts had higher initial (< 24 hr) use of clopidogrel/
ticlopidine and GP IIb-IIIa inhibitors; aspirin and heparin use were lower (all p< 0.05).
Table shows differences in risk level, angiography rates/timing, revascularization rates,
and unadjusted clinical outcomes (all p< 0.02; *25th, 75th percentiles).
Conclusions: The inverse relation between risk level and both frequency and timing of
angiography for pts in both countries suggests that a risk stratification–guided approach
is not consistently employed. While initial risk is lower, Canadian pts have fewer in-hospi-
tal procedures and higher rates of repeat MI.
. 
1097-94 Early Versus Delayed Intervention in Non-ST-Elevation 
Acute Coronary Syndromes: A Natural Experiment 
From the CRUSADE Initiative
Jason W. Ryan, Eric D. Peterson, Anita Chen, Matthew T. Roe, E. Magnus Ohman, 
Christopher P. Cannon, Peter B. Berger, Jorge F. Saucedo, Elizabeth R. DeLong, Charles 
V. Pollack, Jr., David J. Cohen, Beth Israel Deaconess Medical Center, Boston, MA, Duke 
Clinical Research Institute, Durham, NC
Background: Patients with non–ST-elevation acute coronary syndromes (NSTE ACS)
who present on weekends are less likely to receive catheterization within 24 hours than
those presenting during the week. This presents a natural experiment for exploring very
early vs. later intervention and patient outcomes.
Methods: We used the CRUSADE Initiative to compare patient characteristics, treat-
ments, and outcomes for 47,076 patients with NSTE ACS according to the day of presen-
tation. Weekend presentation was defined as 5 pm Friday–7 am Sunday (n=9,063), while
Weekday presentation was defined as any other time (n=38,013).
Results: While admission day had almost no impact on baseline clinical characteristics
and use of most medical treatments, patients admitted on Weekends were only half as
likely to receive catheterization within 24 hours of admission compared with those admit-
ted on a Weekday (p<0.001). Rates of in-hospital adverse events including death and
recurrent MI were similar for the 2 groups. The risk-adjusted odds ratio for mortality for
Weekend vs. Weekday patients was 1.03 (95% CI 0.90-1.12). Findings were similar in
age, and diabetes subgroups, and when the definition of Weekend presentation was
expanded to 7 pm Friday–7 pm Sunday .
Conclusion: Although weekend presentation is associated with modest delays in inva-
sive management among patients with NSTE ACS, in the context of contemporary medi-
cal therapy this does not appear to increase adverse events. 
1097-95 Differences in the Rate of Invasively Confirmed 
Coronary Artery Disease Between Women and Men 
Presenting With an Acute Coronary Syndrome Without 
ST Elevation
Joerg Friedrich, Steffen Schneider, Ulrich Tebbe, Michael Weber, Martin Gottwik, Jochen 
Senges, Uwe Zeymer, for the Arbeitsgemeinschaft Leitende Kardiologische 
Krankenhausärzte (ALKK), Herzzentrum Ludwigshafen, Ludwigshafen, Germany, 
Germany
Objective: do women with acute coronary syndrome (ACS) without ST elevation have a
similar rate of angiographically confirmed coronary artery disease (CAD) and immediate
percutaneous coronary intervention (PCI) as men?
Methods: In 2002 a total of 123328 consecutive invasive procedures were prospectively
enrolled into a central registry. 18070 angiographies were performed in patients with
acute coronary syndrome without ST elevation. 33 % female, mean age 65 years. CAD:
presence of any coronary stenosis > 50 %.
Results:
Table 1: Angiographic diagnosis 
Table 2: Treatment 
Conclusions: In clinical practice coronary angiography in patients presenting with ACS
without ST elevation reveals a higher rate of patients without CAD in women. In patients
with CAD the rate of immediate PCI is similar in women and men.
1097-96 Treatment Bias Against Women With Acute Coronary 
Syndrome: Fact or Fantasy?
Sujoya Dey, Jianming Fang, Firas Marayati, Rich Otten, Kim A. Eagle, University of 
Michigan Medical Center, Ann Arbor, MI
Background: Studies suggest women (W) with acute coronary syndrome (ACS) receive
less aggressive therapy than men (M). This apparent bias may be due to pathophysiology
where W have less obstructive epicardial disease on angiography & thus receive fewer
coronary interventions.
Methods: We compared presentation, coronary anatomy, management & outcomes for
1724 consecutive ACS patients undergoing coronary angiography; defining normal/mild
disease as <50% stenosis in any major epicardial vessel or bypass graft. We examined
PCI/CABG rates, hospital/discharge therapy, & clinical outcomes using univariate statis-
tics/ multiple regression.
Results: W were older, had more heart failure and hypertension, & lower tobacco use.
Despite similar rates of enzyme release, M had higher rates of PCI or CABG. There were
no significant gender differences in 6-month outcomes of death, MI, stroke, or re-hospi-
talization after adjustments for baseline characteristics.
Conclusions:
CRUSADE Canadian ACS I + II
No. of patients 38,373 2,048
Initial risk (%)
Low
Moderate
High
22.7
23.2
50.0
33.2
28.8
38
Rate of angiography by risk
Overall
Low
Moderate
High
63.5
76.9
73.8
51.5
50.2
59.9
55.5
37.9
Median time to angiography (hrs*) by 
risk
Overall
Low
Moderate
High
24 (10,50)
21 ( 6, 41)
23 (9,46)
30(14, 63)
96 (48,168)
96 (48,144)
96 (48,168)
120 (72,192)
Angiography =48 hours of admission 
(%)
42.7 13.4
PCI (%) 37.4 22
CABG (%) 10.7 7.3
Post-admission re MI (%) 4 7.4
Time to catheterization and outcomes
Variable Weekend
N= 9063
Weekday
N= 38013
p value
Mean time to catheterization (hrs) 51.9 37.8 <0.0001
Cath within 6 hrs (%) 9.1 14.9 <0.0001
Cath within 12 hrs (%) 12.0 19.3 <0.0001
Cath within 24 hrs (%) 17.1 34.5 <0.0001
Cath within 48 hrs (%) 33.5 48.7 <0.0001
Death (%) 5.1 4.8 NS
Re-infarction (%) 3.1 3.4 NS
Length of stay (days) median, (25th, 75th percentile) 4 (3, 7) 4 (3, 7) NS
No CAD (%) 8.3 15.2 <0.0001
CAD (%) 89.3 78.5 <0,0001
Other cardiac disease (%) 2.4 6.3 <0,0001
Male n=10897 Female n=4604 p-value
Conservative (%) 24.5 27.9 <0.0001
CABG (%) 20.8 19.1 <0,0001
PCI (%) 54.7 53.0 <0,0001
Immediate PCI performed (%) 49.8 48.1 0.049
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1. W with ACS who undergo coronary angiography have similar rates of STEMI,
NSTEMI, & biomarker release despite differences in baseline characteristics.
2. Evidence based medical therapy is similar except W are less likely to receive lipid low-
ering therapy than M (62% vs. 69% p<0.03)
3. We observed an apparent gender bias in revascularization favoring more PCI/CABG in
M.
4. Treatment bias against W with ACS receiving less revascularization was not due to
gender but rather to differences in severity of epicardial coronary obstruction.
1097-97 Safety of Stress Testing Following an Acute Coronary 
Syndrome
Juhana Karha, Christopher P. Cannon, Sabina A. Murphy, Peter M. DiBattiste, C. Michael 
Gibson, Eugene Braunwald, Brigham and Women's Hospital, Boston, MA
Background: The safety of stress testing within 72 hours following an acute coronary
syndrome has not been established.We hypothesized that performance of a stress test
within 48 to 72 hours after unstable angina (UA) or non-ST segment elevation myocardial
infarction (NSTEMI) would be safe. Methods: Patients (n=1,106) were drawn from the
conservative arm of the TACTICS/TIMI 18 trial. In TACTICS, 2,220 patients with UA/
NSTEMI were treated with aspirin, heparin, and tirofiban, and randomized to an early
invasive strategy or to a conservative strategy in which cardiac catheterization was per-
formed only if the patient had objective evidence of recurrent ischemia or an abnormal
stress test performed within 48 to 72 hours. Results: Of the 847 patients undergoing
stress testing, 494 underwent an exercise treadmill test (mean ± s.d. duration: 7.6 ± 3.2
min), and 353 underwent a pharmacologic stress test with adenosine (n=122), persan-
tine (n=152), or dobutamine (n=79). Per protocol, patients who developed spontaneous
recurrent ischemia prior to stress testing underwent a cardiac catheterization instead,
and a total of 259 patients in the conservative arm did not undergo a stress test. Mortality
at 30 days was 0.94% (8/847) among the patients who underwent a stress test. One of
the deaths occurred on the day of stress testing (mortality = 0.12%). Both of the patients
who died within 24 hours of stress testing had an elevated admission troponin, and one
also had transient ST segment elevation on the admission ECG. Only one patient suf-
fered an MI on the day of stress testing. Conclusions: In patients with UA/NSTEMI
treated with aspirin, heparin, and tirofiban, performance of an exercise or a pharmaco-
logic stress test is safe within 48 to 72 hours after admission.
1097-98 Early Continuous ST Monitoring Identifies Acute 
Coronary Syndrome Patients at High Risk of Death and 
Myocardial Infarction Despite Contemporary Treatment
Andrew T. Yan, Raymond Yan, Mary Tan, David H. Fitchett, Marc Cohen, Paul W. 
Armstrong, Anatoly Langer, Shaun G. Goodman, Canadian Heart Research Centre, 
Toronto, ON, Canada, University of Toronto, Toronto, ON, Canada
Background: Previous small studies suggest continuous ST segment (Holter) monitor-
ing early after presentation can identify high risk patients with acute coronary syndromes
(ACS). However, it is unclear whether this technique remains useful in the contemporary
era of anti-thrombotic therapies.
Methods: In 2 randomized clinical trials comparing enoxaparin with unfractionated hep-
arin ± eptifibatide (INTERACT and ESSENCE ECG substudy), 853 patients with non-ST
elevation ACS underwent early continuous 96 hr Holter monitoring analyzed by an auto-
mated algorithm and reviewed by cardiologists blinded to clinical data. Outcomes at 30
days were independently adjudicated. We examined the prognostic value of Holter-
detected ischemia (HI; >0.1 mV ST deviation >1 min duration).
Results: Of the 853 patients enrolled, 261 (30.6%) had HI (see Table). 
After adjusting for other prognosticators including cardiac biomarker status, HI remained 
a strong predictor of death/MI [OR 3.5 (1.9-6.4), P<0.001] and all-cause mortality [OR 
4.3 (1.6-11.7), P=0.004] at 30 days. In multivariable analysis, renal dysfunction and ST 
deviation were independently associated with HI, while enoxaparin treatment significantly 
reduced the incidence of HI [OR 0.41 (0.28-0.60), P<0.001].
Conclusion: HI is a powerful independent predictor of mortality and MI among ACS 
patients treated in the modern era. This simple tool provides incremental prognostic 
value over the conventional risk stratification of non-ST elevation ACS patients.
1097-99 Racial Differences in Utilization of Primary Prevention 
Strategies and Cardiac Catheterization Following First 
Myocardial Infarction
Jon H. Mojares, Michael P. Hudson, Michelle Jankowski, Keisha R. Sandberg, Henry E. 
Kim, Henry Ford Heart and Vascular Institute, Detroit, MI
Background: Primary prevention strategies such as aspirin, ACE inhibitors and lipid low-
ering drugs may reduce the incidence of myocardial infarction (MI) in patients without
known coronary heart disease. We assessed the hypothesis that racial differences exist
in the implementation of primary prevention strategies.
Methods: In 1571 patients presenting between 1997-2001 with first acute MI and no
prior angina, MI or revascularization, we investigated the presence of racial differences in
the use of primary prevention.
Results: African American (AA) versus Caucasian patients had higher rates of diabetes
and hypertension with lower rates of hyperlipidemia (see table below). Rates of aspirin,
beta blocker, and lipid lowering drug use did not significantly differ according to race;
however, AA patients were more likely to receive ACE inhibitors prior to MI and less likely
to undergo post-MI catheterization.
Conclusions: Minimal differences exist in the use of MI primary prevention strategies
between Caucasian and AA patients. Following first MI, however, AA patients are less
likely to undergo aggressive evaluation with cardiac catheterization and revasculariza-
tion.
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1098-77 TIMI, PURSUIT and GRACE Risk Scores in Acute 
Coronary Syndromes: Comparison and Interaction With 
Myocardial Revascularization
Pedro Araujo Goncalves, Jorge Ferreira, Carlos Aguiar, Marisa Trabulo, Ricardo Seabra-
Gomes, Hospital de Santa Cruz, Carnaxide, Portugal
Background: Regarding prognosis, patients with a non-ST elevation acute coronary syn-
drome (ACS) are a very heterogeneous population, with varying risks of early and long-
term adverse events. Early risk stratification at admission seems to be essential for a tai-
lored therapeutic strategy.
Objective: We sought to compare the prognostic value of three ACS risk scores (RS) and
their ability to predict benefit from myocardial revascularization performed during the ini-
tial hospitalization.
Methods: We studied 460 consecutive patients admitted to our CCU with an ACS. For
each patient, the TIMI, PURSUIT and GRACE RS were calculated. Their prognostic
value was evaluated by the combined incidence of death (D) or myocardial infarction (MI)
at 1 year. The best cut-off value for each RS, was used to assess the impact of myocar-
dial revascularization on D or MI at 1 year.
Results: D or MI at 1 year was 15.4% (32 D/ 49 MI). The best predictive accuracy for D or
Demographics 
M (1123) W (601) P value
Age yrs 62 67 <0.0001
Heart Failure % 17 25 <0.0001
BP systolic mmHg 138 142 0.004
Tobacco % 70 50 <0.0001
Cardiac Enzymes + 72 71 0.44
PCI or CABG % 52 41 <0.0001
PCI % 45 33 <0.0001
CABG % 7.3 8.2 0.49
Angiography %
Normal/mild CAD 31 43 <0.0001
1 vessel 18 16 0.20
2 vessel 16 16 0.88
3 vessel 22 18 0.04
Left main 3.3 2.2 0.18
30-day outcomes Patients without 
Holter Ischemia
(N=592)
Patients with 
Holter Ischemia
(N=261)
Odds Ratio [OR] 
(95% CI)
P value
Death/Myocardial 
Infarction (MI)
3.4% 10.7% 3.4 (1.9-6.2) <0.001
Death 1.0% 5.0% 5.1 (1.9-13.6) 0.001
Caucasian (n=832) African-American (n=739) p-value 
Hypertension 50% 71% <0.001
Diabetes 22% 30% 0.0007
Smoking 61% 61% 0.86
Hyperlipidemia 36% 25% <0.0001
Lipid Lowering Drugs 16% 13% 0.19
Aspirin 21% 19% 0.33
Beta-Blockers 13% 13% 0.19
ACE inhibitors 18% 22% 0.03
Catheterization 61% 43% <0.0001
